Hepatitis B Vaccines Market Revenue 2024 to 2034

Hepatitis B Vaccines Market Revenue 2024 to 2034

The hepatitis B vaccines market, worth USD 6.7 billion in 2024, will reach USD 11.66 billion by 2034, at 5.7% CAGR, supported by global immunization programs and rising government vaccination initiatives.

Report ID: 10484 | Format: Databook | Published: August 2025 | Delivery: Immediate
Download Sample     Customisation Request  

Revenue,

USD 6.70 Bn

Forecast Year,

USD 11.66 Bn

CAGR, 2025 -

5.70%

Report Coverage

Worldwide

Reviewed By

Aditi Shivarkar

Reviewed By

Aman Singh

Hepatitis B Vaccines Market Size Analysis

Hepatitis B Vaccines Market Size By Type 2024 to 2034 (USD )

Type 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Single Antigen4.364.624.905.195.515.846.196.576.967.387.83
Combination2.352.462.592.722.863.003.153.313.483.653.83

Hepatitis B Vaccines Market Size By End-use 2024 to 2034 (USD )

End-use 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Infants3.693.904.144.384.644.925.215.525.856.206.57
Adults3.023.183.353.533.723.924.134.354.594.835.10

Hepatitis B Vaccines Market Size By Distribution 2024 to 2034 (USD )

Distribution 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Public Programs4.024.254.504.765.035.325.635.956.296.657.04
Private2.682.832.993.163.333.523.723.934.154.384.63

Hepatitis B Vaccines Market Size By Region 2024 to 2034 (USD )

Region 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
North America1.881.972.082.192.302.422.552.682.832.973.13
Europe1.681.781.892.012.142.272.412.572.732.903.08
Asia Pacific2.352.462.592.722.863.013.163.323.493.673.85
Latin America0.400.430.460.490.530.560.600.640.690.730.79
Middle East & Africa0.400.430.460.500.540.580.620.660.710.760.82

Hepatitis B Vaccines Market

Hepatitis B Vaccines Market

Our Client